| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | $9,9200 | +0,20% | $177,53M | $206,00 | |
BRR ProCap Financial, Inc. Common Stock | $1,7750 | -4,57% | $177,46M | $303,43K | |
HUMA Humacyte, Inc. Common Stock | $0,62780 | -1,69% | $176,93M | $2,54M | |
HTLM HomesToLife Ltd Ordinary Shares | $1,9200 | +4,92% | $176,68M | $1,38K | |
| $54,4000 | +1,74% | $176,47M | $57,24K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | $16,6400 | -0,60% | $176,30M | $19,89K | |
PAAC Proem Acquisition Corp I Ordinary Shares | $9,9510 | -0,09% | $176,16M | $126,00 | |
BNR Burning Rock Biotech Limited American Depositary Shares | $9,2500 | +3,35% | $176,12M | $1,95K | |
LFCR Lifecore Biomedical, Inc. Common Stock | $4,3300 | -2,26% | $175,91M | $106,83K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | $10,1450 | -0,44% | $175,51M | $10,00K | |
| $3,9000 | +3,45% | $175,38M | $94,27K | |
ECBK ECB Bancorp, Inc. Common Stock | $19,9100 | -1,58% | $175,16M | $7,46K | |
TNXP Tonix Pharmaceuticals Holding Corp. | $9,8850 | -6,92% | $175,02M | $711,39K | |
| $9,0800 | +0,67% | $174,89M | $180,34K | |
DHF BNY Mellon High Yield Strategies Fund | $2,3500 | -0,42% | $174,56M | $588,62K | |
